Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Camtek Ltd. Prospectus 2016

Jul 28, 2016

6712_prs_2016-07-28_74a01719-5351-42f1-a0e2-d68c5e2387d5.zip

Prospectus

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

424B3 1 zk333-194303.htm 424B3 Licensed to: ZKG Document created using EDGARfilings PROfile 4.1.0.0 Copyright 1995 - 2016 Summit Financial Printing, LLC. All rights reserved.

Prospectus Supplement No. 2 (to Prospectus dated April 14, 2014) Filed Pursuant to Rule 424(b)(3) Registration No. 333-194303

6,000,000 Ordinary Shares of

Camtek Ltd.

In this prospectus supplement, references to “we,” “our,” and “us” refer to Camtek Ltd.

Our ordinary shares are listed on the Nasdaq Global Market and on the Tel Aviv Stock Exchange in Israel under the symbol “CAMT.” On July 25, 2016, the last reported sale price of our ordinary shares on the Nasdaq Global Market was $2.67 per share and on July 25, 2016, the last reported sale price of our ordinary shares on the Tel Aviv Stock Exchange was NIS 9.70 (approximately $2.52 per share(.

None of the U.S. Securities and Exchange Commission, the Israeli Securities Authority or any state securities commission have approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense under the laws of the United States and the laws of the State of Israel.

This Prospectus Supplement No. 2 supplements and amends the prospectus dated April 14, 2014, as amended by the prospectus supplement dated May 14, 2015, relating to the offer for sale by the selling shareholder of up to an aggregate of 5,400,000 shares of common stock of Camtek Ltd. or the common stock. You should read this Prospectus Supplement No. 2 in conjunction with the prospectus. This Prospectus Supplement No. 2 is not complete without, and may not be delivered or utilized except in connection with, the prospectus, including any supplements or amendments thereto.

We are providing this prospectus supplement to update the table under the caption “Selling Shareholder” in the prospectus dated April 14, 2014. The following updated information is based upon information provided to us by the selling shareholder and is accurate to our knowledge as of the date of this prospectus supplement. The table below reflects the transfer by Priortech Ltd. of 600,000 shares of common stock in a private sale. The percentage of beneficial ownership is based upon 35,348,176 ordinary shares outstanding as of March 17, 2016.

Name of Selling Shareholder — Priortech Ltd. 16,919,739 5,400,000 11,519,739 32.6 %

The date of this Prospectus Supplement No. 2 is July 28, 2016